Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 69Rectal Neoplasms 10Triple Negative Breast Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Lung Neoplasms 6Carcinoma, Intraductal, Noninfiltrating 6Adenocarcinoma of Lung 6Breast Carcinoma In Situ 4Pancreatic Neoplasms 2Unilateral Breast Neoplasms 1Transsexualism 1Solitary Pulmonary Nodule 1Social Isolation 1Recurrence 1Piebaldism 1Patient Satisfaction 1Pain, Postoperative 1Neoplastic Cells, Circulating 1Neoplasm Micrometastasis 1Margins of Excision 1Lymphedema 1Local Recurrence of Malignant Tumor of Breast 1Inflammatory Breast Neoplasms 1Gynecomastia 1Gastrointestinal Stromal Tumors 1Colorectal Neoplasms 1Chordoma 1Carcinoma, Lobular 1Carcinoma, Ductal, Breast 1Carcinoma, Ductal 1

Interventions

Letrozole 6Radiotherapy 4Carboplatin 4atamestane 3Trastuzumab 3Toremifene 3Magnetic Resonance Spectroscopy 3Fulvestrant 3Docetaxel 3Cyclophosphamide 3Chemotherapy, Adjuvant 3Tamoxifen 2Paclitaxel 2Gene Expression Profiling 2Estrogen Receptor Modulators 2Capecitabine 2Aromatase Inhibitors 2Amplified Fragment Length Polymorphism Analysis 2repotrectinib 1proto-oncogene protein c-fes-fps 1palbociclib 1neratinib 1gallium 68 PSMA-11 1fluciclovine F-18 1entrectinib 1Zolpidem 1Vorinostat 1Vinorelbine 1Venlafaxine Hydrochloride 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Lobular × Mastectomy, Segmental × Clear all
NCT05919108 2025-09-09

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

Vanderbilt-Ingram Cancer Center

Phase 2 Recruiting
30 enrolled

Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡